Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
🟢 New in Current Filing
The proposed combination of our Biosciences and Diagnostic Solutions business with Waters may not be completed, on the currently contemplated timeline or at all.
🔒
🟢 New in Current Filing
The announcement and pendency of the combination of our Biosciences and Diagnostic Solutions business with Waters could cause disruptions in our business.
🔒
🟢 New in Current Filing
We may not realize some or all of the expected benefits of the combination of our Biosciences and Diagnostic Solutions business with Waters.
🔒
🟡 Modified
Cybersecurity incidents and breaches or breakdowns of our information and technology systems or infrastructure could have a material adverse effect on our operations.
🔒
🟡 Modified
We are subject to extensive regulation.
🔒
🟡 Modified
Our international operations subject us to certain business risks.
🔒
🟡 Modified
Market dynamics, changes in reimbursement practices and coverage policies, third-party payer cost containment measures and health insurance coverage levels could affect demand for our products and the prices at which they are sold.
🔒
🔴 No Match in Current Filing
We are subject to risks associated with public health crises, such as pandemics and epidemics, which could have a material adverse effect on our business. The nature and extent of impacts from any such events are highly uncertain and unpredictable.
🔒
🟡 Modified
Climate change and related sustainability efforts, or legal, regulatory or market measures to address these efforts, could adversely affect our business, financial condition or results of operations.
🔒
🟡 Modified
The medical technology industry is very competitive.
🔒
🟡 Modified
Global economic conditions, including inflation and supply chain disruptions, could continue to adversely affect our operations.
🔒
🟡 Modified
Cost volatility could adversely affect our operations.
🔒
🟡 Modified
Interruption of our manufacturing or sterilization operations could adversely affect our business.
🔒
🟡 Modified
We are subject to foreign currency exchange risk.
🔒
🟡 Modified
Natural disasters, public health crises, war and other events beyond our control could disrupt our business and adversely affect our future revenues and operating income.
🔒
🟡 Modified
Human Capital Management
🔒
🟡 Modified
Information About our Executive Officers
🔒
🟡 Modified
We are subject to lawsuits.
🔒
🟡 Modified
Defects or quality issues associated with our products and related regulatory actions could adversely affect our results of operations and financial statements.
🔒
🟡 Modified
Reductions in customers’ research budgets or government funding may adversely affect our business.
🔒
🟡 Modified
Forward-Looking Statements
🔒
🟡 Modified
The agreements that govern our indebtedness impose restrictions that may affect our ability to operate our businesses.
🔒
🟡 Modified
Risks Relating to the Spin-off of Embecta Corp.
🔒